NRX Pharmaceuticals (NRXP) Return on Assets (2018 - 2026)

NRX Pharmaceuticals (NRXP) has 9 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• On a quarterly basis, Return on Assets rose 1.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.08%, up 4.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.01%, down from 0.01% in the prior quarter.
• Over the last five years, Return on Assets for NRXP reached as high as 0.01% in Q4 2025 and fell as low as 0.05% in Q2 2024.
• Historically, Return on Assets has averaged 0.03% across 5 years, with a median of 0.02% in 2022.
• Across the five-year window, Return on Assets gained 9 bps in 2022 and fell 4 bps in 2024, its largest moves.
• Year by year, Return on Assets stood at 0.02% in 2022, then dropped by 17 bps to 0.02% in 2023, then sank by 109 bps to 0.05% in 2024, then surged by 75 bps to 0.01% in 2025, then slipped by 20 bps to 0.01% in 2026.
• Per Business Quant data, the three most recent Return on Assets figures were 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.